- Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
- AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024
- Amwell Releases 2024 Corporate Responsibility Report
- Amwell to Participate in Upcoming Investor Conference
- Amwell® to Report First Quarter 2024 Operating Results May 1
- Amwell Receives Continued Listing Standard Notice From NYSE
- Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
- Amwell Names Cynthia Horner, M.D., Chief Medical Officer
- Amwell Expands Presence in Australia with Amplar Health Partnership
- Amwell Executives to Take the Stage at ViVE 2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.40 |
---|---|
High | 0.4083 |
Low | 0.37 |
Bid | 0.37 |
Offer | 0.39 |
Previous close | 0.3896 |
Average volume | 1.88m |
---|---|
Shares outstanding | 296.46m |
Free float | 241.73m |
P/E (TTM) | -- |
Market cap | 115.65m USD |
EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.
More ▼